JUL 18, 2016 12:21 PM PDT

Hybrid Lymphocytes Zap Cancer

WRITTEN BY: Kara Marker
For the first time in a human tumor, scientists from the Perelman School of Medicine at the University of Pennsylvania have discovered a “hybrid lymphocyte” - part neutrophil and part antigen-presenting cell. Will learning more about this immune cell lead to a new generation of cancer immunotherapy drugs?

In their study published in Cancer Cell, Pennsylvania scientists aimed to characterize the so-called tumor-associated neutrophil (TAN) that was found at high levels in the microenvironment of tumors in samples of early-stage lung cancer. Neutrophils are normally first-responders to an infection site, killing pathogens by engulfing them and releasing perforating enzymes. Antigen-presenting cells include a variety of different lymphocytes that intercept pathogens and display pieces of them on their cell surface for cells like T lymphocytes to recognize, warning them of an invasion. 
How Cancer Immunity Works | Image: journal.frontiersin.org
During their research, the scientists wanted to know how TANs helped reduce tumor volume. In order to potentially manipulate TAN activity for future immunotherapies, they would need to understand TAN function first. The researchers investigated closely how TAN activity affected the response of cytotoxic T cells, another immune cell type that aggressively targets tumors.

“Our findings demonstrate that the early-stage lung tumor microenvironment can drive neutrophils to differentiate into a cell subset with enhanced anti-tumor capabilities,” explained coauthor of the study Sunil Singhal, MD. “Interestingly, this hybrid population disappears as tumors enlarge.”

In addition to targeting and fighting cancer cells, cytotoxic T cells kill viruses, bacteria, and even protozoa. Cytotoxic T cells cleverly cause death in foreign cells by reprogramming their cellular machinery so they will undergo apoptosis, a process of programmed cell death.

“Perhaps if we can expand the hybrid neutrophils in patients early on, we can augment anti-tumor T cell activity,” suggested senior author of the study Evgeniy B. Eruslanov, PhD. Considering the role of cytotoxic T cells in other pathologies in addition to cancer, therapy using hybrid neutrophils could be useful for multiple diseases in the future. 
 


Sources: University of Pennsylvania School of Medicine, Immunobiology: The Immune System in Health and Disease. 5th edition., PubMed Health, Nature
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 26, 2018
Immunology
SEP 26, 2018
What Superbug? A New Antibiotic Contender
Scientists from a biotechnology corporation, Genentech, have altered a protein that blocks a signaling pathway in gram-negative bacteria to engineer a new antibiotic, currently called G0775,...
OCT 01, 2018
Immunology
OCT 01, 2018
Fate of the T Cell
The immune system consists of a variety of different cell types. But how do the cells undergo differentiation? A study recently published in Science provides insight....
NOV 14, 2018
Immunology
NOV 14, 2018
Stress in Youth Can Mean Depression as an Adult
A research team investigates early life stress and its relation to adult depression and anxiety...
DEC 09, 2018
Immunology
DEC 09, 2018
A Better Human Immune System: In Mice
We've cured cancer and autoimmune disease in mice many times over....
DEC 18, 2018
Immunology
DEC 18, 2018
Enhancing Antibody Validation and Reproducibility
Many immunological technologies are only as good as the antibody being used for antigen detection. As such, there is enormous value with providing the scie...
DEC 19, 2018
Immunology
DEC 19, 2018
UTI Infection Becoming a Common Reoccurrence?
Researchers have shed new light on the connection between recurring urinary tract infections and the bacterial strain involved...
Loading Comments...